ZA200104697B - Compositions and methods for amelioration of human female sexual dysfunction. - Google Patents

Compositions and methods for amelioration of human female sexual dysfunction.

Info

Publication number
ZA200104697B
ZA200104697B ZA200104697A ZA200104697A ZA200104697B ZA 200104697 B ZA200104697 B ZA 200104697B ZA 200104697 A ZA200104697 A ZA 200104697A ZA 200104697 A ZA200104697 A ZA 200104697A ZA 200104697 B ZA200104697 B ZA 200104697B
Authority
ZA
South Africa
Prior art keywords
methods
female sexual
sexual dysfunction
amelioration
compositions
Prior art date
Application number
ZA200104697A
Other languages
English (en)
Inventor
James L Yeager
Nadir Buyuktimkin
Servet Buyuktimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of ZA200104697B publication Critical patent/ZA200104697B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200104697A 1998-12-10 2001-06-08 Compositions and methods for amelioration of human female sexual dysfunction. ZA200104697B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/208,965 US6486207B2 (en) 1998-12-10 1998-12-10 Compositions and methods for amelioration of human female sexual dysfunction

Publications (1)

Publication Number Publication Date
ZA200104697B true ZA200104697B (en) 2002-08-28

Family

ID=22776778

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104697A ZA200104697B (en) 1998-12-10 2001-06-08 Compositions and methods for amelioration of human female sexual dysfunction.

Country Status (19)

Country Link
US (1) US6486207B2 (xx)
EP (1) EP1137409B1 (xx)
JP (1) JP4616480B2 (xx)
KR (1) KR100660239B1 (xx)
CN (1) CN1173700C (xx)
AT (1) ATE265849T1 (xx)
AU (1) AU760112B2 (xx)
BR (1) BR9916076A (xx)
CA (1) CA2354695C (xx)
DE (1) DE69917066T2 (xx)
DK (1) DK1137409T3 (xx)
ES (1) ES2217878T3 (xx)
HK (1) HK1039067B (xx)
HU (1) HU229083B1 (xx)
IL (2) IL143661A0 (xx)
MX (1) MXPA01005748A (xx)
PT (1) PT1137409E (xx)
WO (1) WO2000033825A2 (xx)
ZA (1) ZA200104697B (xx)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20050004226A1 (en) * 1998-12-10 2005-01-06 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
EA008720B1 (ru) * 1998-12-10 2007-06-29 Нексмед (Холдингс), Инк. Применение композиции на основе простагландина для лечения расстройства сексуального возбуждения у женщин
WO2000059491A2 (en) * 1999-04-06 2000-10-12 Zonagen, Inc. Methods for modulating the human sexual response
US20010029268A1 (en) * 1999-07-01 2001-10-11 Thompson Ronald J. Clitoral sensitizing arrangement using compound of menthol and L-arginine
US20050244520A1 (en) * 1999-07-01 2005-11-03 40J's Llc Topical menthol, or a related cooling compound, to induce lubrication
US6702733B1 (en) * 1999-07-01 2004-03-09 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
US6464628B1 (en) * 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
IL139454A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
BR0108223B1 (pt) * 2000-02-10 2009-08-11 aparelho mecánico para o tratamento de impotência.
EP1255513B1 (en) * 2000-02-14 2005-05-25 Potencia Medical AG Penile prosthesis
US6762202B2 (en) * 2000-05-09 2004-07-13 Nitromed, Inc. Infrared thermography and methods of use
US20020052370A1 (en) * 2000-07-06 2002-05-02 Barber Christopher Gordon Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
GB2372213B (en) * 2000-11-17 2003-07-16 Icebella Enterpises Ltd Applicator and stimulator device
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US6673841B2 (en) * 2001-12-20 2004-01-06 Whan In Pharm. Co., Ltd. Alprostadil alkyl ester-containing composition for external application
GB0130704D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd New use
US20030220292A1 (en) * 2002-02-15 2003-11-27 Nexmed (Holdings), Inc. Treatment of erectile dysfunction
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
GB0225908D0 (en) * 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
JP2006520788A (ja) * 2003-03-21 2006-09-14 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物による血管形成促進および方法
US20040241244A1 (en) * 2003-03-21 2004-12-02 Nexmed (Holdings) Inc. Neuronal growth enhancement by prostaglandin compositions and methods
JP2006522136A (ja) * 2003-04-02 2006-09-28 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物および血管痙攣の治療のためのその使用
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005051960A2 (en) * 2003-11-22 2005-06-09 Midwest Research Laboratories, Llc Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents
PL1720611T3 (pl) * 2004-02-16 2010-09-30 Proteosys Ag Marker diagnostyczny dla raka
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
WO2007051563A1 (en) 2005-11-02 2007-05-10 Prosthesica Ag Implantable infusion device with advanceable and retractable needle
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009048382A1 (en) * 2007-10-11 2009-04-16 Milux Holding Sa Apparatus for treating female sexual dysfunction
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
ES2876250T3 (es) * 2007-10-11 2021-11-12 Implantica Patent Ltd Aparato para controlar el flujo en un órgano corporal
EP2214570B1 (en) 2007-10-11 2021-08-04 Implantica Patent Ltd. Apparatus and system for the treatment of female sexual dysfunction
US8992409B2 (en) * 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
WO2009048392A1 (en) 2007-10-11 2009-04-16 Milux Holding Sa A system, an apparatus, and a method for treating a sexual dysfunctional female patient
HUE058738T2 (hu) 2007-10-11 2022-09-28 Implantica Patent Ltd Készülék nõi nemi diszfunkció kezelésére
WO2010042045A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
US8696543B2 (en) * 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
CA2999337C (en) 2008-01-28 2023-03-07 Implantica Patent Ltd. An implantable drainage device
HUE055034T2 (hu) 2008-01-29 2021-10-28 Implantica Patent Ltd Készülék stimulálóeszközzel reflux betegség kezelésére
WO2010042046A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. Apparatus, system and operation method for the treatment of female sexual dysfunction
CA2776450C (en) 2008-10-10 2018-08-21 Peter Forsell Heart help device, system, and method
EP2349096B1 (en) 2008-10-10 2021-01-27 MedicalTree Patent Ltd. An improved artificial valve
PL2349383T3 (pl) 2008-10-10 2022-09-19 Medicaltree Patent Ltd. Urządzenie i system wspomagania serca
WO2010042044A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
AU2009302955B2 (en) 2008-10-10 2017-01-05 Implantica Patent Ltd. Fastening means for implantable medical control assembly
WO2010040556A2 (en) 2008-10-10 2010-04-15 Milux Holding Sa Stimulation of sexually responsive tissue of the vulva
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
PT2952191T (pt) 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776366C (en) 2009-10-02 2017-07-18 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2011343429B2 (en) 2010-12-16 2016-10-20 Sunovion Pharmaceuticals Inc. Sublingual films
CA2838109C (en) 2011-04-07 2020-06-09 Nexmed Holdings, Inc. Topical semisolid prostaglandin e1 composition for treating raynaud's disease
CA2745320A1 (en) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
WO2015172102A1 (en) * 2014-05-09 2015-11-12 Nexmed Holdings, Inc. Treating female sexual arousal disorder and related symptoms
CA3127926A1 (en) 2015-04-21 2016-10-27 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US10130578B2 (en) * 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
IL258017B (en) * 2018-03-11 2019-10-31 Aquafit Intimate Ltd Cervical device and its uses

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3639561A (en) 1970-04-29 1972-02-01 Smith Kline French Lab Vaginal suppositories and impregnated tampons
US3852465A (en) 1972-09-21 1974-12-03 Upjohn Co Abortion by myometrial administration of prostaglandins
US4005221A (en) 1974-04-01 1977-01-25 Karim Sultanali M M Use of prostaglandins to induce menstruation
US4217360A (en) 1975-02-27 1980-08-12 Schering Aktiengesellschaft Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
US4043339A (en) 1976-02-02 1977-08-23 The Upjohn Company Method of and vaginal insert for prostaglandin administration
JPS52156913A (en) 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
AU519132B2 (en) 1978-01-31 1981-11-12 Kureha Kagaku Kogyo K.K. Prostaglandin-steroid conjugates
US4254145A (en) 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS5573676A (en) 1978-11-30 1980-06-03 Ono Pharmaceut Co Ltd Simulated compound of prostaglandin i2 and its preparation
JPS5589297A (en) 1978-12-28 1980-07-05 Kureha Chem Ind Co Ltd Prostaglandin derivative, its preparation and its drug
SE431821B (sv) 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
US4311707A (en) 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
USRE30439E (en) 1979-03-12 1980-11-25 The Upjohn Company Treatment of genital tract diseases of domestic animals with prostaglandins
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4289785A (en) 1980-08-06 1981-09-15 The Upjohn Company Method and compositions involving prostaglandins
ZA831186B (en) 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4515810A (en) 1983-10-06 1985-05-07 American Cyanamid Company Composition of matter
JPS61249934A (ja) * 1985-04-27 1986-11-07 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4820732A (en) 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4889845A (en) 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
US4771004A (en) 1986-08-29 1988-09-13 Iprx, Inc. Method for in vitro determination of transdermal absorption
EP0266968A3 (en) 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
JPS63135333A (ja) 1986-11-26 1988-06-07 Nitto Electric Ind Co Ltd プロスタグランジン類含有貼付剤
US5219885A (en) 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
IT1221826B (it) 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
JP2910857B2 (ja) 1989-04-04 1999-06-23 ニチバン株式会社 プロスタグランジンｅ１経皮吸収製剤
JP2926749B2 (ja) * 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5059603A (en) 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
AU655420B2 (en) 1990-04-25 1994-12-22 Vivus, Inc. Treatment of erectile dysfunction
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU2300092A (en) 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
AU658681B2 (en) 1991-10-23 1995-04-27 Block Drug Company Inc., The Penetration enhancement of topically applied formulations
US5773457A (en) 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5324746A (en) 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
AU688792B2 (en) 1993-10-27 1998-03-19 Pharmacia & Upjohn Company Stabilized prostaglandin e1
US5380760A (en) 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
NZ305560A (en) 1995-03-14 1998-11-25 Vivus Inc Method for preventing erectile dysfunction by administering vasoactive agent, particularly a prostaglandin, kit therefor
US5661178A (en) 1995-09-01 1997-08-26 Allergan Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
US6036977A (en) 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
US20020004529A1 (en) 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US5891915A (en) 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
US6031002A (en) 1998-05-01 2000-02-29 Michael Ebert Method for enhancing female sexual response and a composition therefor

Also Published As

Publication number Publication date
MXPA01005748A (es) 2003-07-14
WO2000033825A2 (en) 2000-06-15
ES2217878T3 (es) 2004-11-01
IL143661A (en) 2006-06-11
CN1330543A (zh) 2002-01-09
DE69917066D1 (de) 2004-06-09
CA2354695A1 (en) 2000-06-15
HUP0200067A2 (en) 2002-06-29
US20020028846A1 (en) 2002-03-07
KR20020068257A (ko) 2002-08-27
CN1173700C (zh) 2004-11-03
JP2002531494A (ja) 2002-09-24
EP1137409B1 (en) 2004-05-06
CA2354695C (en) 2005-01-25
KR100660239B1 (ko) 2006-12-20
HUP0200067A3 (en) 2005-03-29
JP4616480B2 (ja) 2011-01-19
DE69917066T2 (de) 2005-04-28
PT1137409E (pt) 2004-08-31
BR9916076A (pt) 2001-09-04
HU229083B1 (en) 2013-07-29
AU2358600A (en) 2000-06-26
ATE265849T1 (de) 2004-05-15
HK1039067B (zh) 2004-10-08
AU760112B2 (en) 2003-05-08
US6486207B2 (en) 2002-11-26
DK1137409T3 (da) 2004-08-02
WO2000033825A3 (en) 2000-11-16
EP1137409A2 (en) 2001-10-04
HK1039067A1 (en) 2002-04-12
IL143661A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
IL143661A0 (en) Compositions and methods for amelioration of human female sexual dysfunction
WO2004004689A8 (en) Compositions and methods for amelioration of human female sexual dysfunction
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
EP1028720A4 (en) METHODS, COMPOSITIONS AND KITS FOR STIMULATING SEXUAL DESIRE AND SENSIBILITY IN WOMEN
BG103646A (en) Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases
WO1997044063A3 (en) Dha-pharmaceutical agent conjugates
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
HUP0101268A3 (en) Pharmaceutical compositions for treating female sexual dysfunction
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
UA86345C2 (ru) Применение остеопротегерина для лечения и/или предотвращения фиброза
UA90077C2 (uk) Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
DE59807248D1 (de) Implantatkörper
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
WO2002072021A3 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
GB2388777A (en) Compositions containing gangliosides for use in the treatment of skin disorders
PL361179A1 (en) Treatment of cancers
IL139303A0 (en) Treatment of arthritis and other similar conditions
AU1871497A (en) An aphrodisiac for application to the sexual organs
GB2325855A8 (en) Preperation for topical application to the male sexual organ comprising at least one vasodilator & an aloe extract as active ingredients in an aq cream or gel
WO2000002579A3 (en) Component b as angiogenic agent in combination with human growth factors